Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients - PWR 12.02.2022
powernephron
Published on Dec 13, 2022
Dr. Karen Shalansky, Dr. Kevin Kwok, Dr. Hilary Wu present, "Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients."
Category
- Your Subscription
powernephron -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
35:15
Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
100 views 1419 days ago -
25:08
HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
69 views 1214 days ago -
24:13
Gestational and Chronic Hypertension - CRASH! Medical Review Series
52 views 962 days ago -
47:17
Renin angiotensin system blockade in COVID-19: A tumultuous year in review
61 views 1395 days ago -
52:24
New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF
95 views 1395 days ago -
30:35
Christopher Blosser, MD - Cancer in Patients with Kidney Disease
56 views 1217 days ago